Mechanisms of Nanoparticle-Mediated siRNA Transfection by Melittin-Derived Peptides

被引:79
作者
Hou, Kirk K. [1 ]
Pan, Hua [2 ]
Ratner, Lee [2 ]
Schlesinger, Paul H. [3 ]
Wickline, Samuel A. [2 ,3 ,4 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO 63108 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63108 USA
[3] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63108 USA
[4] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63108 USA
基金
美国国家卫生研究院;
关键词
siRNA; endosomolysis; melittin; drug delivery; nanoparticle; NF-KAPPA-B; CELL-PENETRATING-PEPTIDE; SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; ENDOCYTIC PATHWAYS; CATIONIC LIPIDS; DELIVERY; THERAPEUTICS; TOXICITY; CHALLENGES;
D O I
10.1021/nn403311c
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Traditional peptide-mediated siRNA transfection via peptide transduction domains exhibits limited cytoplasmic delivery of siRNA due to endosomal entrapment. This work overcomes these limitations with the use of membrane-destabilizing peptides derived from melittin for the knockdown of NFkB signaling in a model of adult T-cell leukemia/lymphoma. While the mechanism of siRNA delivery into the cytoplasmic compartment by peptide transduction domains has not been well studied, our analysis of melittin derivatives indicates that concurrent nanocomplex disassembly and peptide-mediated endosomolysis are crucial to siRNA transfection. Importantly, in the case of the most active derivative, p5RHH, this process is initiated by acidic pH, indicating that endosomal acidification after macropinocytosis can trigger siRNA release into the cytoplasm. These data provide general principles regarding nanocomplex response to endocytosis, which may guide the development of peptide/siRNA nanocomplex-based transfection.
引用
收藏
页码:8605 / 8615
页数:11
相关论文
共 71 条
[1]   Cell-penetrating-peptide-based delivery of oligonucleotides: an overview [J].
Abes, R. ;
Arzumanov, A. A. ;
Moulton, H. M. ;
Abes, S. ;
Lvanciva, G. D. ;
Lversen, P. L. ;
Gait, M. J. ;
Lebleu, B. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :775-779
[2]   Constitutive Expression of Short Hairpin RNA in Vivo Triggers Buildup of Mature Hairpin Molecules [J].
Ahn, M. ;
Witting, S. R. ;
Ruiz, R. ;
Saxena, R. ;
Morral, N. .
HUMAN GENE THERAPY, 2011, 22 (12) :1483-1497
[3]   Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity [J].
Akhtar, Saghir ;
Benter, Ibrahim .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :164-182
[4]   Attacking the genome: emerging siRNA nanocarriers from concept to clinic [J].
Alabi, Christopher ;
Vegas, Arturo ;
Anderson, Daniel .
CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (04) :427-433
[5]   FRET-Labeled siRNA Probes for Tracking Assembly and Disassembly of siRNA Nanocomplexes [J].
Alabi, Christopher A. ;
Love, Kevin T. ;
Sahay, Gaurav ;
Stutzman, Tina ;
Young, Whitney T. ;
Langer, Robert ;
Anderson, Daniel G. .
ACS NANO, 2012, 6 (07) :6133-6141
[6]   Polycation-based nanoparticle delivery of RNAi therapeutics: Adverse effects and solutions [J].
Ballarin-Gonzalez, Borja ;
Howard, Kenneth Alan .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (15) :1717-1729
[7]   The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphornas [J].
Bernal-Mizrachi, Leon ;
Lovly, Christine M. ;
Ratner, Lee .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) :9220-9225
[8]   Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteins [J].
Caron, NJ ;
Quenneville, SP ;
Tremblay, JP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (01) :12-20
[9]   Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells [J].
Chiu, YL ;
Ali, A ;
Chu, CY ;
Cao, H ;
Rana, TM .
CHEMISTRY & BIOLOGY, 2004, 11 (08) :1165-1175
[10]   Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo [J].
Chou, S-T ;
Leng, Q. ;
Scaria, P. ;
Woodle, M. ;
Mixson, A. J. .
CANCER GENE THERAPY, 2011, 18 (10) :707-716